TL;DR
This study investigates the link between apolipoprotein E (APOE) gene variations and aneurysmal subarachnoid hemorrhage (aSAH) in a Chinese population. They found that a specific APOE genotype (ε2) is associated with an increased risk of aSAH, potentially mediated by altered plasma ApoE levels and lipid profiles.
What Problem Does This Paper Address?
Aneurysmal subarachnoid hemorrhage (aSAH) is a severe and often fatal neurological emergency with high morbidity and mortality. While it's known to be influenced by both genetic and environmental factors, the specific genetic predispositions are not fully understood, especially in diverse populations. Previous studies on the role of APOE polymorphism in aSAH have yielded inconsistent results, and there's a particular lack of evidence from Chinese Han populations. This paper aims to clarify the association between APOE gene variations and aSAH risk in this demographic and explore potential underlying mechanisms involving serum lipids and ApoE protein levels.
Methods
This was a case-control study. Researchers recruited 131 patients newly diagnosed with aSAH and 137 age- and gender-matched healthy individuals as controls. They collected blood samples to analyze:
- Blood lipids: Standard lipid profiles including total cholesterol (TC), triglycerides (TG), HDL-C, LDL-C, ApoA1, and ApoB were measured using an automated biochemistry analyzer.
- APOE Genotype: APOE genotypes were determined using a commercial genotyping chip and confirmed with Sanger sequencing.
- Statistical Analysis: Multivariate logistic regression was employed to assess the association between APOE polymorphism and aSAH risk, adjusting for age and gender. Independent t-tests and Chi-square tests were used for comparisons between groups.
Datasets
The study utilized data from:
- aSAH Group: 131 patients newly diagnosed with aSAH from the First Affiliated Hospital of Fujian Medical University.
- Control Group: 137 healthy individuals undergoing routine health check-ups at the same hospital.
No new benchmarks were introduced; the study focused on analyzing existing clinical and genetic data within these defined groups.
Key Insights and Ideas
- APOE ε2 as a Risk Factor: The study provides evidence that the APOE ε2 allele is an independent risk factor for aSAH in the studied Chinese population. This is a significant finding, as previous research has been conflicting.
- Lipid Profile Differences: Patients with aSAH exhibited significantly lower levels of total cholesterol (TC), HDL-C, and ApoA1 compared to controls. This suggests that dyslipidemia might play a role in the pathogenesis of aSAH.
- Elevated Plasma ApoE in aSAH: Interestingly, serum ApoE levels were found to be significantly higher in aSAH patients than in controls. This contrasts with the lower levels of other lipids and suggests a complex interplay.
- Potential Mechanism: The authors propose that the ε2 allele's association with aSAH might be linked to its impact on serum lipid levels and plasma ApoE concentration, potentially affecting neuroprotection or vascular health.
Key Results
- Genotype Distribution: The ε2/ε3 genotype was found more frequently in the aSAH group (19.08%) compared to controls (9.49%) (P=0.038).
- Allele Frequency: The APOE ε2 allele frequency was significantly higher in the aSAH group (11.07%) than in the control group (5.84%) (P=0.039).
- Logistic Regression: After adjusting for age and gender, the APOE ε2 allele was independently associated with an increased risk of aSAH (OR = 2.083; 95% CI = 1.045-4.153, P = 0.037). The ε4 allele did not show a significant association.
- Serum Lipids: aSAH patients had significantly lower TC (4.52 ± 1.38 vs. 5.11 ± 0.86 mmol/L), HDL-C (1.23 ± 0.46 vs. 1.44 ± 0.32 mmol/L), and ApoA1 (1.20 ± 0.32 vs. 1.38 ± 0.25 g/L) compared to controls (all P < 0.001).
- Plasma ApoE: Serum ApoE levels were significantly higher in the aSAH group (53.03 ± 24.64 mg/L) compared to controls (45.06 ± 12.84 mg/L) (P = 0.010).
Limitations and Future Work
The authors acknowledge several limitations:
- Dietary Influence: The study did not account for the impact of diet on lipid profiles, which can be influenced by nutraceuticals and functional foods.
- Single-Center Study: All patients were recruited from a single hospital, potentially introducing selection bias.
- Exclusion of Deceased/Withdrawn Patients: Individuals who died or withdrew from emergency treatment were not included, which could lead to Neyman bias.
- Small Sample Size: The relatively small number of cases admitted for this study might limit the generalizability of the findings.
Future work suggested includes:
- Larger Population Studies: Conducting studies with larger sample sizes is crucial to confirm these findings.
- Mechanistic Investigations: Further research is needed to fully elucidate the molecular mechanisms by which APOE genotypes influence serum lipids and plasma ApoE levels, and how these, in turn, contribute to aSAH.
- Broader Genetic and Environmental Factors: Investigating the interplay of APOE with other genetic factors and environmental influences would provide a more comprehensive understanding of aSAH risk.
Summary updated